Kukje Pharma Co., Ltd. (KRX:002720)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,830.00
+10.00 (0.21%)
At close: Jun 26, 2025, 3:30 PM KST
-19.50%
Market Cap 97.13B
Revenue (ttm) 160.43B
Net Income (ttm) 4.31B
Shares Out 20.36M
EPS (ttm) 211.66
PE Ratio 22.54
Forward PE n/a
Dividend 30.00 (0.62%)
Ex-Dividend Date Mar 13, 2025
Volume 166,565
Average Volume 133,552
Open 4,815.00
Previous Close 4,820.00
Day's Range 4,695.00 - 4,830.00
52-Week Range 4,285.00 - 7,840.00
Beta 0.87
RSI 48.53
Earnings Date Aug 14, 2025

About Kukje Pharma

Kukje Pharma Co., Ltd. engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, quinolones, tetracycline, aminoglycosides, macrolides, other antibiotics, ophthalmic, antifungal and antiviral agents, ophthalmic agents, adrenal corticosteroids, CNS and osteoporotic agents, antihistamines, NSAID... [Read more]

Sector Healthcare
Founded 1959
Employees 244
Stock Exchange Korea Stock Exchange
Ticker Symbol 002720
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.